| Latest | F'cast | |
|---|---|---|
| Div Yield | 2.1% | 0.0% |
| Div Cover | 2.4 | 2.6 |
| Op Mrgn | 13.0% | 22.4% |
| ROCE | 26.3% |
| Latest | F'cast | |
|---|---|---|
| P/E | 19.3 | 17.0 |
| PEG | 1.2 | 1.3 |
| Pr/Revenue | 2.7 | 1.9 |
| Pr/Book | 4.4 |
| Latest | F'cast | |
|---|---|---|
| Revenue | 6.6% | -22.6% |
| PBT | -6.5% | 84.0% |
| EPS | 15.7% | 12.8% |
| DPS | 12.9% | -41.7% |
| Year Ending | Revenue ($m) | Pre-tax ($m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 31-Dec-21 | 2,038.30 | 151.30 | 13.10¢ | 20.0 | 2.5 | +8% | 5.87¢ | 2.2% |
| 31-Dec-22 | 2,072.50 | 81.90 | 12.70¢ | 24.8 | n/a | -3% | 6.05¢ | 1.9% |
| 31-Dec-23 | 2,142.40 | 167.40 | 13.40¢ | 24.7 | 4.1 | +6% | 6.23¢ | 1.9% |
| 31-Dec-24 | 2,289.00 | 246.00 | 15.30¢ | 19.6 | 1.4 | +14% | 6.42¢ | 2.1% |
| 31-Dec-25 | 2,439.00 | 230.00 | 17.70¢ | 18.6 | 1.2 | +16% | 7.24¢ | 2.2% |
a. Based on UK GAAP presentation of accounts - includes discontinued activities
| Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 31-Dec-26 | 2,555.88 | 573.01 | 14.77p | 17.1 | 1.3 | +13% | 5.72p | 0.0% |
| 31-Dec-27 | 2,710.07 | 636.48 | 16.64p | 15.1 | 1.2 | +13% | 6.26p | 0.0% |
Copyright © 2026 FactSet Research Systems Inc. All rights reserved.
| Convatec FY25 Results | 24-Feb-2026 | 07:00 | RNS |
| Holding(s) in Company | 06-Feb-2026 | 11:00 | RNS |
| Total Voting Rights | 02-Jan-2026 | 11:00 | RNS |
| Convatec boosts outlook after strong year, share... | 24-Feb-2026 | ShareCast |
| Holding(s) in Company | 19-Dec-2025 | ShareCast |
| Convatec slumps on Novo Holdings exit | 18-Nov-2025 | ShareCast |
| Convatec raises outlook with new specialist medi... | 25-Feb-2026 | Times |
No deals were found in the last 28 days.
| Currency | UK Pounds |
| Share Price | 253.80p |
| Change Today | 2.00p |
| % Change | 0.79 % |
| 52 Week High | 295.40 |
| 52 Week Low | 220.00 |
| Volume | 621,552 |
| Shares Issued | 1,954.85m |
| Market Cap | £4,961.41m |
| Beta | 0.78 |
| RiskGrade | 96 |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income |
|
|---|
| Growth |
|
|---|
| Strong Buy | 8 |
| Buy | 7 |
| Neutral | 2 |
| Sell | 0 |
| Strong Sell | 0 |
| Total | 17 |

| Latest | Previous | |
|---|---|---|
| Final | Interim | |
| Ex-Div | 16-Apr-26 | 21-Aug-25 |
| Paid | 28-May-26 | 01-Oct-25 |
| Amount | 5.37¢ | 1.88¢ |
| Time | Volume / Share Price |
| 11:01 | 3 @ 253.80p |
| 11:01 | 1,000 @ 253.80p |
| 11:01 | 73 @ 253.80p |
| 11:01 | 29 @ 254.00p |
| 11:00 | 13 @ 253.80p |
| Chair | John McAdam |
| CEO | Jonny Mason |
| CFO | Fiona Ryder |
You are here: research